Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Share Price
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EGP | -2.46% | -4.35% | +20.00% |
Sales 2024 * | 291.77Cr 6.21Cr 517.89Cr | Sales 2025 * | 342.89Cr 7.29Cr 608.64Cr | Capitalization | 296.62Cr 6.31Cr 526.5Cr |
---|---|---|---|---|---|
Net income 2024 * | 38Cr 81.03L 68Cr | Net income 2025 * | 51Cr 1.09Cr 91Cr | EV / Sales 2024 * | 1.38 x |
Net Debt 2024 * | 106.67Cr 2.27Cr 189.34Cr | Net Debt 2025 * | 77Cr 1.63Cr 135.97Cr | EV / Sales 2025 * | 1.09 x |
P/E ratio 2024 * |
6.66
x | P/E ratio 2025 * |
5.56
x | Employees | - |
Yield 2024 * |
4.19% | Yield 2025 * |
6.72% | Free-Float | 50.28% |
1 day | -2.46% | ||
1 week | -4.35% | ||
Current month | -3.88% | ||
1 month | -22.66% | ||
3 months | -13.91% | ||
6 months | +31.91% | ||
Current year | +20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 01/11/01 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 01/19/01 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 01/20/01 |
Director/Board Member | 65 | 01/19/01 | |
Director/Board Member | - | 01/11/01 |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 1.99 | +0.51% | 3,385,068 |
12/24/12 | 1.98 | -2.46% | 3,499,406 |
09/24/09 | 2.03 | -1.46% | 5,342,341 |
08/24/08 | 2.06 | -1.44% | 4,638,050 |
End-of-day quote Egyptian Exchange, May 12, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.00% | 6.23Cr | |
+29.98% | 68TCr | |
+30.34% | 57TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- RMDA Stock